Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--II. Biochemical properties.
In vivo anti-LAP monoclonal antibody enhances IL-17/IFN-γ responses and abrogates anti-CD3 induced oral tolerance.
How can we exploit the brain's ability to repair itself?
Interferon Beta and Glatiramer Acetate Therapy.
Myelin oligodendrocyte glycoprotein induces aquaporin-4 autoantibodies in mouse experimental autoimmune encephalomyelitis.
Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells.
[Association between polymorphisms of cytokine genes and the rate of multiple sclerosis progression.]
B cells contribute to MS pathogenesis through antibody-dependent and antibody-independent mechanisms.
Expert recommendations to personalization of medical approaches in treatment of Multiple Sclerosis: an overview of family planning and pregnancy.
Antibodies to potassium channels in multiple sclerosis.
Expanded Disability Status Scale (EDSS) estimation in multiple sclerosis from posturographic data.
Assessment and rehabilitation of driver skills: subjective experiences of people with multiple sclerosis and health professionals.
Quantitative determination of regional lesion volume and distribution in children and adults with relapsing-remitting multiple sclerosis.
Estimating the Cost-Effectiveness of OnabotulinumtoxinA for Neurogenic Detrusor Overactivity in the United States.
The effects of bortezomib on the immune system: a focus on immune regulation.
What do people with MS want from a web-based resource to encourage increased physical activity behaviour?
Relationship Between Cerebrospinal Fluid Protein Levels and Electrophysiologic Abnormalities in Guillain-Barré Syndrome.
Baseline brain activity changes in patients with clinically isolated syndrome revealed by resting-state functional MRI.
Factors affecting anxiety in multiple sclerosis.
The precise chemical-physical nature of the pharmacore in FK506 binding protein inhibition: ElteX, a new class of nanomolar FKBP12 ligands.
Onset of secondary progressive phase and long-term evolution of multiple sclerosis.
Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders.
Involvement of ER Stress in Dysmyelination of Pelizaeus-Merzbacher Disease with PLP1 Missense Mutations Shown by iPSC-Derived Oligodendrocytes.
Advances in Antioxidative Therapy of Multiple Sclerosis.
Minocycline-induced attenuation of iron overload and brain injury after experimental intracerebral hemorrhage.

Pages